CELIAC DISEASE ANTIBODY SELF-TEST - ANVISA Registration 81086830053

Access comprehensive regulatory information for CELIAC DISEASE ANTIBODY SELF-TEST in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81086830053 and manufactured by VEDALAB. The registration is held by FASTTEST DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including BIOSYNEX SA, CHEMBIO DIAGNOSTICS BRAZIL LTDA., and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
3 Competitors
81086830053
Registration Details
ANVISA Registration Number: 81086830053
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

81086830053

25351652120202251

20037992000139

Company Information

VEDALAB
France
PT: FRANÇA

Dates and Status

Jan 16, 2023

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "CELIAC DISEASE ANTIBODY SELF-TEST"